GCT at NYC Medical Technology Forum

Thursday, September 12th GCT Business Development team represented by Nataliya Katsnelson, BD Director and Elizaveta Medvedeva, BD Associate had a pleasure of participating in the NYC MedTech Forum. The presentations by the key speakers on the new NASH treatment method by Enzychem Lifesciences, Neuroimaging methods in detecting Alzheimer’s Disease by Frank A. Provenzano, and Hospital sequencing-based solutions by Biotia were mind-blowing. The forum was also a wonderful opportunity to connect with fellow professionals in the industry.

We are looking forward to the next year’s event!

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.